Kalaris Therapeutics, Inc. Common Stock (NASDAQ: KLRS) last traded at $2.23, down 1.33% on the session. The quote above updates while this page is open; the figures below are drawn from Kalaris Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Kalaris Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker KLRS. Its market capitalisation is $53.09 million.
Valuation measures for Kalaris Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $53.09M |
|---|---|
| Enterprise value | $51.78M |
| Price / book | 0.92 |
| Beta | 0.85 |
Trailing-twelve-month figures tagged in Kalaris Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$44.26M |
| Return on equity | -76.75% |
|---|
| Cash | $43.17M |
|---|
Range and volume for KLRS over the past 52 weeks.
| 52-week high | $11.88 |
|---|---|
| 52-week low | $2.20 |
| Volume | 73.2K |
| Average volume | 252.4K |
| Previous close | $2.26 |
Invest a chosen dollar amount in Kalaris Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell KLRS.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.